finanzen.net
23.10.2018 01:00
Bewerten
(0)

The global digital therapeutics market was valued at $1,751 million in 2017 and is expected to reach $7,833 million by 2025

DRUCKEN

LONDON, Oct. 22, 2018 /PRNewswire/ -- Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Diseases (CVD), Central Nervous System (CNS) Disease, Gastrointestinal Disorders (GID), Respiratory Diseases, Smoking Cessation, and Others), Product (Software and Devices), and Sales Channel (Business-to-business [B2B] and Business-to-consumers [B2C]): Global Opportunity Analysis and Industry Forecast, 2017 - 2025

Download the full report: https://www.reportbuyer.com/product/5591591

The global digital therapeutics market was valued at $1,751 million in 2017 and is expected to reach $7,833 million by 2025, registering a CAGR of 20.5% during the forecast period. Digital therapeutics is a type of treatment option, which utilizes online health technologies and digital devices to treat numerous medical conditions and help maintain health discipline.

Increase in adoption of smartphones & tablets coupled with rise in utilization of healthcare apps is the major factor that drives the growth of the global digital therapeutics market. In addition, increasing need to control healthcare costs supplements the market growth. However, lack of awareness regarding the availability of smartphone applications, especially in the developing countries, acts a major deterrent to the market growth. Conversely, high growth potential in the developing markets is expected to offer significant opportunities for the players operating in this market.

The global digital therapeutics market is segmented into application, product, sales channel, and region. Based on application, the market is divided into diabetes, obesity, cardio vascular diseases (CVD), central nervous system (CNS) disease, respiratory diseases, smoking cessation, gastrointestinal disorders, and others. On the basis of product, it is classified into software and devices. By sales channel, it is bifurcated into business-to-business (B2B) and business-to-consumers (B2C). Furthermore, the business - to - business (B2B) segment is categorized into employers, healthcare providers, and others. Depending on business-to-consumers, the market is fragmented into patients and caregivers. Regionally, it is analyzed across North America, Europe, Asia - Pacific, and LAMEA.

Key benefits for Digital Therapeutics Market :

The study provides an in-depth analysis of the global digital therapeutics market along with current trends and future estimations to elucidate the imminent investment pockets.

Comprehensive analysis of the factors that drive and restrict the market growth is provided.

Comprehensive quantitative analysis of the industry from 2017 to 2025 is provided to enable stakeholders to capitalize on the prevailing market opportunities.

Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally.

Key market players and their strategies are provided to understand the competitive outlook of the market.

Digital Therapeutics Key market segments :

By Application
Diabetes

Obesity

Cardiovascular Disease (CVD)

Central Nervous System (CNS) Disease

Respiratory Disease

Smoking Cessation

Gastrointestinal Disorder (GID)

Others

By Product
Software

Device

By Sales Channel
Business-to-business (B2B)

Employer

Healthcare Provider

Others

Business-to-consumer (B2C)

Patient

Caregiver

By Region
North America

U.S.

Canada

Mexico

Europe

UK

Germany

France

Italy

Spain

Rest of Europe

Asia-Pacific

Japan

China

Australia

India

South Korea

Rest of Asia-Pacific

LAMEA

Brazil

Turkey

Saudi Arabia

South Africa

Rest of LAMEA

Download the full report: https://www.reportbuyer.com/product/5591591

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: sarah@reportbuyer.com
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com

Cision View original content:http://www.prnewswire.com/news-releases/the-global-digital-therapeutics-market-was-valued-at-1-751-million-in-2017-and-is-expected-to-reach-7-833-million-by-2025--300735481.html

SOURCE ReportBuyer

Anzeige
Anzeige
Börse Stuttgart Anlegerclub

Fünf deutsche Internet-Aktien, die Sie kennen sollten!

Das Gute liegt oft so nah. Heimische Internet-Unternehmen rollen den Markt auf. Im neuen Anlegermagazin erwartet Sie ein Special über deutsche Internet-Aktien, die Sie kennen sollten.
Kostenfrei registrieren und lesen!

Heute im Fokus

DAX beendet Tag im Plus -- Dow legt zu -- EU lehnt Italiens Haushaltsplan ab -- thyssenkrupp: 'Zahlen schlecht, Aussichten unklar' -- Daimler, VW, Covestro, NVIDIA, Apple im Fokus

Covestro-Aktie erholt sich vom Kurssturz. May: Ablehnung des Brexit-Deals im Parlament könnte Austritt stoppen. OECD sieht Weltwirtschaft in schwierigem Fahrwasser. SAP will ungerechte Bezahlung beseitigen. Deutsche Bank weist Mitverantwortung im Danske-Skandal zurück. Renault bekommt vorläufig neue Führung.

Die 5 beliebtesten Top-Rankings

Das sind die kreativsten Unternehmen der Welt
Welcher Global Player ist vorne mit dabei?
Diese Autobauer machen den meisten Profit
Größte Marge bei verkauften Autos
Netter Bonus
Auf soviel Weihnachtsgeld dürfen sich Arbeitnehmer 2018 in Deutschland freuen
Erster Job
Wo Absolventen am meisten Geld verdienen
Das hat sich geändert
Diese Aktien hat George Soros im Depot
mehr Top Rankings

Umfrage

Wo steht der DAX Ihrer Einschätzung nach Ende 2018?

finanzen.net Brokerage

Online Brokerage über finanzen.net

Das Beste aus zwei Welten: Handeln Sie für nur 5 Euro Orderprovision* pro Trade unmittelbar aus der Informationswelt von finanzen.net!
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Deutsche Bank AG514000
Wirecard AG747206
Amazon906866
Daimler AG710000
Apple Inc.865985
NVIDIA Corp.918422
CommerzbankCBK100
Aurora Cannabis IncA12GS7
Deutsche Telekom AG555750
Covestro AG606214
BASFBASF11
BayerBAY001
EVOTEC AG566480
Volkswagen (VW) AG Vz.766403
Infineon AG623100